Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Incident HIV infection has fallen rapidly in men who have sex with men in Melbourne, Australia (2013–2017) but not in the newly-arrived Asian-born

Authors: Nicholas A. Medland, Eric P. F. Chow, Timothy H. R. Read, Jason J. Ong, Marcus Chen, Ian Denham, Praveena Gunaratnum, Christopher K. Fairley

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

We examined differences in incident HIV infection between newly-arrived Asian-born and other men who have sex with men (MSM) after the introduction of universal HIV treatment guidelines in 2015 and pre-exposure prophylaxis in 2016.

Methods

Clinical, demographic, laboratory and behavioural data on MSM presenting for HIV testing at the Melbourne Sexual Health Centre from July 2013 to June 2017 were extracted. We compared the proportion of newly-arrived (four years or less in Australia), Asian-born and other MSM tested each year who were diagnosed with incident HIV infection (negative test within one year or diagnosis with indeterminate or negative Western Blot).

Results

We analysed 35,743 testing episodes in 12,180 MSM, including 2781 testing episodes in 1047 newly-arrived Asian-born MSM. The proportion of other MSM tested each year who were diagnosed with incident HIV infection fell from 0.83% in 2014 to 0.38% in 2017 (p = .001), but did not fall in newly-arrived Asian-born MSM (from 1.18% in 2014 to 1.56% in 2017, p = .76). In the multivariate logistic regression, in 2016/2017 but not in 2014/2015, being newly-arrived Asian-born was associated with an increased odds of diagnosis of incident HIV infection (aOR 3.29, 95%CI 1.82–5.94, p < .001).

Conclusions

The epidemiology of HIV in Melbourne Australia has changed dramatically. While there has been an overall reduction amongst MSM, the incidence of HIV in newly-arrived Asian-born MSM remains high. Failing to address these new inequalities leaves individuals at risk and may offset the population benefit of biomedical HIV prevention.
Appendix
Available only for authorised users
Literature
2.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830–9. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830–9.
3.
go back to reference Mayer KH, Krakower DS. Editorial commentary: scaling up antiretroviral Preexposure prophylaxis: moving from trials to implementation. Clin Infect Dis. 2015;61(10):1598–600.CrossRefPubMedPubMedCentral Mayer KH, Krakower DS. Editorial commentary: scaling up antiretroviral Preexposure prophylaxis: moving from trials to implementation. Clin Infect Dis. 2015;61(10):1598–600.CrossRefPubMedPubMedCentral
4.
go back to reference Goldschmidt RH. Preexposure prophylaxis in the United States: an evolving HIV prevention opportunity. Clin Infect Dis. 2017;64(2):150–1.CrossRefPubMed Goldschmidt RH. Preexposure prophylaxis in the United States: an evolving HIV prevention opportunity. Clin Infect Dis. 2017;64(2):150–1.CrossRefPubMed
5.
go back to reference Mayer KH, Krakower DS. Antiretrovirals for HIV treatment and prevention: the challenges of success. Jama. 2016;316(2):151–3.CrossRefPubMed Mayer KH, Krakower DS. Antiretrovirals for HIV treatment and prevention: the challenges of success. Jama. 2016;316(2):151–3.CrossRefPubMed
6.
go back to reference Nwokolo N, et al. Rapidly declining HIV infection in MSM in Central London. Lancet HIV. 2017;4(11):e482–3.CrossRefPubMed Nwokolo N, et al. Rapidly declining HIV infection in MSM in Central London. Lancet HIV. 2017;4(11):e482–3.CrossRefPubMed
7.
go back to reference Smith DK, et al. Vital signs: estimated percentages and numbers of adults with indications for Preexposure prophylaxis to prevent HIV acquisition--United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291–5.CrossRefPubMed Smith DK, et al. Vital signs: estimated percentages and numbers of adults with indications for Preexposure prophylaxis to prevent HIV acquisition--United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291–5.CrossRefPubMed
10.
go back to reference Zablotska I, et al. PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers. J Int AIDS Soc. 2016;19(7(Suppl 6)):21119.PubMedPubMedCentral Zablotska I, et al. PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers. J Int AIDS Soc. 2016;19(7(Suppl 6)):21119.PubMedPubMedCentral
11.
go back to reference Sidibe M, Zuniga JM, Montaner J. Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction. Clin Infect Dis. 2014;59(Suppl 1):S3–6.CrossRefPubMedPubMedCentral Sidibe M, Zuniga JM, Montaner J. Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction. Clin Infect Dis. 2014;59(Suppl 1):S3–6.CrossRefPubMedPubMedCentral
13.
go back to reference The Centre for Population Health Burnet Institute. HIV/AIDS Monthly Surveillance Report December 2016. In: Victoria State Government Department of Health and Human Services, editor. Melbourne, Australia 2017. The Centre for Population Health Burnet Institute. HIV/AIDS Monthly Surveillance Report December 2016. In: Victoria State Government Department of Health and Human Services, editor. Melbourne, Australia 2017.
18.
go back to reference Song A, et al. HIV and sexual health knowledge and sexual experience among Australian-born and overseas-born students in Sydney. J Adolesc Health. 2005;37(3):243.CrossRefPubMed Song A, et al. HIV and sexual health knowledge and sexual experience among Australian-born and overseas-born students in Sydney. J Adolesc Health. 2005;37(3):243.CrossRefPubMed
19.
go back to reference National Pathology Accreditation Advisory Council. Requirements for Laboratory Testing for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). In: Australian Government Department of Health, editor. Third Edition ed. Canberra, Australia 2013. National Pathology Accreditation Advisory Council. Requirements for Laboratory Testing for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). In: Australian Government Department of Health, editor. Third Edition ed. Canberra, Australia 2013.
22.
go back to reference Medland NA, et al. Time from HIV infection to virological suppression: dramatic fall from 2007 to 2016. Aids. 2017;31(17):2377–85.CrossRefPubMed Medland NA, et al. Time from HIV infection to virological suppression: dramatic fall from 2007 to 2016. Aids. 2017;31(17):2377–85.CrossRefPubMed
23.
go back to reference von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.CrossRefPubMedPubMedCentral von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.CrossRefPubMedPubMedCentral
24.
go back to reference Benchimol EI, et al. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.CrossRefPubMedPubMedCentral Benchimol EI, et al. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.CrossRefPubMedPubMedCentral
25.
go back to reference Chow EPF, et al. Assortative sexual mixing patterns in male-female and male-male partnerships in Melbourne, Australia: implications for HIV and sexually transmissible infection transmission. Sex Health. 2016;13(5):451–6.PubMed Chow EPF, et al. Assortative sexual mixing patterns in male-female and male-male partnerships in Melbourne, Australia: implications for HIV and sexually transmissible infection transmission. Sex Health. 2016;13(5):451–6.PubMed
26.
go back to reference Gunaratnam P, McManus H, Watchirs-Smith L, McGregor S, Callander D, Brown G, Lobo R, O'Connor C, Hellard M, Medland N, Lewis D, Palmer C, Law M, Gray R, Donovan B, Guy R. People Born in Non-Main English Speaking Countries Are Less Likely to Start HIV Treatment Early in Australia: A National Cohort Analysis, 2014-15. J Acquired Immune Defic Syndr (1999). 2018;77(3):e31–4. Gunaratnam P, McManus H, Watchirs-Smith L, McGregor S, Callander D, Brown G, Lobo R, O'Connor C, Hellard M, Medland N, Lewis D, Palmer C, Law M, Gray R, Donovan B, Guy R. People Born in Non-Main English Speaking Countries Are Less Likely to Start HIV Treatment Early in Australia: A National Cohort Analysis, 2014-15. J Acquired Immune Defic Syndr (1999). 2018;77(3):e31–4.
27.
go back to reference Medland NA, et al. Obstacles to prescribers’ initiation early antiretroviral therapy: a barrier to achieving 90-90-90 goals. Lancet HIV. 2016;3(12):e559–60.CrossRefPubMed Medland NA, et al. Obstacles to prescribers’ initiation early antiretroviral therapy: a barrier to achieving 90-90-90 goals. Lancet HIV. 2016;3(12):e559–60.CrossRefPubMed
28.
go back to reference Cornelisse VJ, et al. Concordance of chlamydia infections of the rectum and urethra in same-sex male partnerships: a cross-sectional analysis. BMC Infect Dis. 2017;17(1):22.CrossRefPubMedPubMedCentral Cornelisse VJ, et al. Concordance of chlamydia infections of the rectum and urethra in same-sex male partnerships: a cross-sectional analysis. BMC Infect Dis. 2017;17(1):22.CrossRefPubMedPubMedCentral
29.
Metadata
Title
Incident HIV infection has fallen rapidly in men who have sex with men in Melbourne, Australia (2013–2017) but not in the newly-arrived Asian-born
Authors
Nicholas A. Medland
Eric P. F. Chow
Timothy H. R. Read
Jason J. Ong
Marcus Chen
Ian Denham
Praveena Gunaratnum
Christopher K. Fairley
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3325-0

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue